Table 1.
Protein name/ accession number |
Molecular weight (Da) | Position | Peptide sequence | Domain | Sequence coverage (%) | Expected value | Protein score | Retention time (min) | Mass |
---|---|---|---|---|---|---|---|---|---|
Nucleoprotein/ NCAP_SARS2 |
45,598 |
33–38 62–68 94–100 101–107 144–149 196–203 250–256 294–299 362–369 |
SGARSK EDLKFPR IRGGDGK MKDLSPR SAAEASK NSTPGSSR QGTDYK DHIGTR TFPPTEPK |
NTD NTD NTD NTD NTD SR-rich linker SR-rich linker CTD CTD |
14 | 2.8e−05 | 71 |
1.748 10.009 8.99 14.535 11.876 3.106 8.141 4.463 17.195 |
605.3003 905.3679 702.3656 846.4745 663.2919 805.4151 711.3777 699.3434 916.4878 |
Spike Glycoprotein/ SPIKE_SARS2 |
141,088 |
35–41 196–202 238–246 305–310 409–417 458–466 530–535 568–577 815–825 987–995 1020–1028 1039–1045 |
GVYYPDK NIDGYFK FQTLLALHR SFTVEK QIAPGQTGK KSNLKPFER STNLVK DIADTTDAVR RSFIEDLLFNK VEAEVQIDR ASANLAATK RVDFCGK |
NTD NTD NTD NTD RBD RBD SD1 SD1 FP – HR HR |
7 | 3.5e−05 | 70 |
15.271 14.761 11.536 8.141 7.293 7.293 5.765 8.537 8.537 8.537 14.535 16.515 |
840.3916 855.4207 1099.5145 711.3777 898.4402 559.2666 660.3676 538.2224 1381.5842 1059.4718 846.4745 824.4274 |
Membrane/ VME1_SARS2 |
25,130 |
43–50 151–158 175–180 181–186 |
NRFLYIIK IAGHHLGR TLSYYK LGASQR |
– | 12 | 0.0031 | 51 |
19.514 15.836 7.01 10.065 |
1065.5635 859.4678 774.3603 632.3762 |
ORF3a/ AP3A_SARS2 |
31,103 |
22–30 62–67 69–75 193–198 |
DATPSDFVR IITLKK WQLALSK WESGVK |
– | 10 | 0.0067 | 47 |
8.537 7.575 14.535 6.387 |
1007.4616 716.3357 846.4745 704.3564 |
ORF8/ NS8_SARS2 |
13,822 |
45–52 95–101 116–121 |
WYIRVGAR LGSLVVR VVLDFI |
– | 17 | 0.011 | 45 |
11.536 10.009 6.387 |
1021.46 371.655 704.3564 |
Envelope/ VEMP_SARS2 |
8360 |
62–69 64–69 70–75 |
VKNLNSSR NLNSSR VPDLLV |
CTD | 18 | 0.012 | 38 |
7.575 14.705 2.653 |
916.4513 689.3618 655.3016 |
Placeholder TextPeptides with 7 amino acids or higher are considered as plausible sequences for further analyses